Passage Bio, Inc. Stock Analysis & AI Score
Passage Bio, Inc. (PASG) has an ST Score of 30.5 (C-), driven by its Forecast (B+) and held back by its Profitability (F). Analysts rate it Buy with a $10.00 price target (+108.3% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Passage Bio, Inc. (PASG) has an ST Score of 30.5 (C-), driven by its Forecast (B+) and held back by its Profitability (F). Analysts rate it Buy with a $10.00 price target (+108.3% upside).
- Strongest
- ForecastB+
- Weakest
- ProfitabilityF
All factor grades
- ForecastB+
- ValuationC
- Financial StrengthC
- GrowthC-
- MomentumD+
- ProfitabilityF
- Piotroski1/9
Contact
PASG stock: frequently asked questions
What is PASG's ST Score?
Passage Bio, Inc. (PASG) has an ST Score of 30.5 (C-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is PASG a buy, hold, or sell?
Analysts rate PASG a Buy, with a price target of $10.00 (+108.3% vs the current price). Our ST Score grades it C- (30.5/100). The ST Score is a data-driven signal, not a recommendation.
What are PASG's factor grades?
Valuation C, Profitability F, Financial Strength C, Momentum D+, Growth C-, Forecast B+.
What is PASG's valuation grade?
Passage Bio, Inc. (PASG) earns a valuation grade of C, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is PASG's growth grade?
Passage Bio, Inc. (PASG) earns a growth grade of C-, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is PASG's profitability grade?
Passage Bio, Inc. (PASG) earns a profitability grade of F, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is PASG's financial strength grade?
Passage Bio, Inc. (PASG) earns a financial strength grade of C, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for PASG?
The average analyst price target for Passage Bio, Inc. (PASG) is $10.00 from 11 analysts, which is +108.3% versus the recent price of $4.80.
What is PASG's Piotroski score?
Passage Bio, Inc. (PASG) has a Piotroski F-Score of 1 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.